SEC Form 4 · accession 0001437749-26-022630
Monopar Therapeutics · MNPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chandler Robinson
Officer — Chief Executive Officer · Director
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 7:38 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001645469
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 30, 2026 | M | 12,873 | — | A | 103,351 | D | |
| Common StockF2 | Jun 30, 2026 | F | 4,084 | $92.59 | D | 99,267 | D | |
| Common StockF3 | holding | — | — | — | 62,815 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F4,F5,F6 | — | Jun 30, 2026 | M | 12,873 | D | — | — | Common Stock | 12,873 | 93,403 | D |
Explanation of responses
- F1Represents shares acquired on vesting and settlement of restricted stock units.
- F2Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- F3Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
- F4On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- F5On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- F6On December 2, 2025, the reporting person was granted 49,133 restricted stock units, vesting 6/48ths (6,142) on June 30, 2026, and 3/48ths (3,071 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.